Difference between revisions of "UMODL1-AS1"

From LncRNAWiki
Jump to: navigation, search
 
Line 1: Line 1:
 
==Annotated Information==
 
==Annotated Information==
 +
[[File:LncRNA signature for recurrence based on RNA expression.jpg|right|thumb|400px|'''LncRNA signature for recurrence based on RNA expression'''<ref name="ref1" />]]
 +
[[File:Alterations of lncRNAs associated with ER, PR and HER-2.png|right|thumb|480px|'''Alterations of lncRNAs associated with ER, PR and HER-2'''<ref name="ref1" />]]
 
===Approved Symbol===
 
===Approved Symbol===
 
UMODL1-AS1 (UMODL1 antisense RNA 1)
 
UMODL1-AS1 (UMODL1 antisense RNA 1)
[[File:LncRNA signature for recurrence based on RNA expression.jpg|right|thumb|400px|'''LncRNA signature for recurrence based on RNA expression'''<ref name="ref1" />]]
 
[[File:Alterations of lncRNAs associated with ER, PR and HER-2.png|right|thumb|400px|'''Alterations of lncRNAs associated with ER, PR and HER-2'''<ref name="ref1" />]]
 
 
===Previous Symbols===
 
===Previous Symbols===
 
C21orf128
 
C21orf128

Latest revision as of 13:14, 7 January 2018

Annotated Information

LncRNA signature for recurrence based on RNA expression[1]
Alterations of lncRNAs associated with ER, PR and HER-2[1]

Approved Symbol

UMODL1-AS1 (UMODL1 antisense RNA 1)

Previous Symbols

C21orf128

Synonyms

FLJ33471

Chromosome

21q22.3

RefSeq ID

NR_027243

Disease

breast cancer

Ensembl ID

ENSG00000184385

Function

UMODL1-AS1's upregulation can predict recurrence of breast cancer.[1] UMODL1-AS1 is significantly associated with ER and triple negative status.[1]

Labs working on this lncRNA

  • Cancer Institute, University of Mississippi Medical Center, Jackson, MS, USA. [1]

References

  1. 1.0 1.1 1.2 1.3 1.4 1: Liu H, Li J, Koirala P, Ding X, Chen B, Wang Y, Wang Z, Wang C, Zhang X, Mo YY. Long non-coding RNAs as prognostic markers in human breast cancer.Oncotarget. 2016 Apr 12;7(15):20584-96. doi: 10.18632/oncotarget.7828.